Sophia Genetics
Tracked across 4 events · 29 articles · First seen Apr 16, 2026 · Last active Aug 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Sophia Genetics partnered with Synnovis to launch MSK-ACCESS powered with SOPHiA DDM, expanding its AI-driven precision medicine platform for cancer testing in the United Kingdom.
May 13, 2026 · 7 articles
Business
Impact: Sophia Genetics is undergoing a planned leadership transition, with a new CEO and Chairman of the Board, aiming for continuity and accelerated growth.
Jun 10, 2026 · 7 articles
Business
Impact: Sophia Genetics is conducting a public offering of its ordinary shares to raise approximately $50 million, which will impact its capital structure and financial liquidity.
Jun 16, 2026 · 7 articles
Business
Impact: Sophia Genetics is the primary developer of the companion diagnostics, and this collaboration validates its technology and expands its commercial opportunities, likely positively impacting its financial performance and market valuation.
Aug 04, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Sophia Genetics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard